시장보고서
상품코드
1081222

세계의 소프트젤 캡슐 시장 : 종류별, 용도별, 제조업체별 시장 규모, 산업 분석, 지역별 전망, 성장 가능성, 경쟁 시장 점유율, 예측(2022-2030년)

Softgel Capsules Market Size By Type, By Application, By Manufacturers, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030

발행일: | 리서치사: Global Market Insights Inc. | 페이지 정보: 영문 205 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 소프트젤 캡슐 시장 규모는 세계에서 만성질환이 증가하고 있어, 2030년까지 큰 성장을 보일 것으로 예상됩니다.

또한 식물 유래 캡슐에 대한 수요 증가, 연구개발(R&D) 활동·투자 급증도 시장 성장을 더욱 지지할 것으로 생각됩니다.

종류별로는 식물성 캡슐 분야가 분석기간 중에 9.3% 이상의 CAGR로 성장할 것으로 예상됩니다. 용도별로는 처방약 부문이 2021년에 20억 달러 이상의 매출을 차지하고, 향후 몇 년간 현저하게 성장할 것으로 생각됩니다. 제조업체별로는 뉴트라슈티컬 기업이 약 43%의 시장 점유율을 차지할 전망입니다.

세계의 소프트젤 캡슐(Softgel Capsules) 시장에 대해 분석했으며, 업계의 기본 구조와 매력, 기술·규제 환경, 주요 시장 성장 촉진·억제요인, 종류별·용도별·제조업체별·지역별 시장 동향 전망, 주요 기업 개요·실적·전략 등을 조사했습니다.

목차

제1장 분석 방법

제2장 주요 요약

제3장 소프트젤 캡슐 산업 인사이트

  • 산업 세분화
  • 산업 상황(2017-2030년)
  • 업계에 대한 영향요인
    • 성장 촉진요인
    • 업계의 잠재적 위험과 과제
  • 성장 가능성 분석
  • COVID-19의 영향 분석
  • Porter's Five Forces 분석
  • 경쟁 상황(2021년)
    • 경쟁 매트릭스 분석(2021년)
  • PESTEL 분석

제4장 소프트젤 캡슐 시장 : 종류별

  • 주요 부문 동향
  • 젤라틴 기반
    • 시장 규모 : 지역별(단위 : 100만 달러, 2017-2030년)
  • 식물성 캡슐

제5장 소프트젤 캡슐 시장 : 용도별

  • 주요 부문 동향
  • 건강식품·식이보충제
    • 비타민
    • 효소
    • 오메가 3
    • 미네랄
    • 기타
  • 처방약
    • 항생물질과 항바이러스제
    • 진해제·감기약
    • 기타

제6장 소프트젤 캡슐 시장 : 제조업체별

  • 주요 부문 동향
  • 제약 기업
  • 뉴트라슈티컬 기업

제7장 소프트젤 캡슐 시장 : 지역별

  • 지역별 주요 동향
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 한국
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
  • 중동 및 아프리카
    • 사우디아라비아
    • 남아프리카공화국
    • 아랍에미리트

제8장 기업 개요

  • 경쟁 대시보드(2021년)
  • Eurocaps Ltd.
  • Catalent Inc.
  • Capsugel(Lonza)
  • Aenova Group GmbH
  • Sirio Pharma Co.
  • Procaps Group
  • Captek Softgel International Inc.
  • Patheon
  • Fuji Capsules Co. Ltd.
  • Estrellus
  • Curtis Health Caps
  • Delpharm Evreux
  • Guangdong Yichao Biological Co. Ltd.
KSM 22.06.20

The softgel capsules market is anticipated to showcase significant growth by 2030 owing to the growing prevalence of chronic diseases around the globe. In addition, increasing demand for plant-based capsules, along with surging investments in research and development activities, is likely to further bolster market growth through the forecast period.

Softgel capsules are semi-solid soft gel-like drug capsules that carry medicine and dissolve faster than hard capsules. They are made of pectin, HPMC, gelatin, potato starch, pullulan, and other materials. Notably, during the COVID-19 pandemic, the industry witnessed steady growth amid changing lifestyle preferences. Higher demand for vitamin and health supplements to improve the immune system, which promotes a healthy lifestyle, has contributed to rising technological advancements, thereby boosting market growth.

Moreover, key participants in the industry have been engaging in R&D activities and lucrative strategies like collaborations, partnerships, and acquisitions, thereby enhancing overall market dynamics. For instance, in October 2020, Catalent Inc., a leading pharmaceutical company, launched OptiGel DR technology that combines pectin and gelatin to make softgel capsules without a coating system.

In another instance, in September 2021, Aenova Group, a major pharmaceutical manufacturer, along with partner companies Wiley Companies-subsidiary AlaskOmega AG and Algarithm, an algae DHA oils provider, introduced a new vegetable-based softgel capsule named VegaGels. The vegan capsule contains omega-3 DHA fatty acids derived from microalgae. The new softgels are chewable and are available in several flavors.

The softgel capsules market has been bifurcated based on manufacturers, type, application, and region. By type, the market has been split into gelatin based and vegetarian capsules.

The vegetarian capsules segment is expected to grow at a CAGR of over 9.3% through the analysis period. High consumer preference for vegetarian softgel capsules, notable technological advancements in plant-based softgel capsules, and the availability of natural raw materials are likely to further fuel segmental growth.

With regards to application, the softgel capsules market has been divided into prescription medicine, health & dietary supplements, and others. The prescription medicine segment accounted for more than $2 billion in revenue in 2021 and is projected to grow prominently in the forthcoming years due to high adoption rate of treatments for chronic diseases, better therapeutic outcomes, and growing number of product approvals and launches.

With respect to manufacturers, the softgel capsules market has been segregated into nutraceutical companies, pharmaceutical companies, and others. In 2021, the nutraceutical companies segment held a market share of nearly 43% and is anticipated to amass significant gains by 2030. The emerging trend of healthy lifestyles, soaring interest in dietary supplements to improve physical appearance, and mounting incidences of obesity and sedentary lifestyles are set to augment segmental growth.

In the regional landscapes, the Latin America softgel capsules market is estimated to grow at a CAGR of approximately 4.5% from 2022 to 2030 as a result of rising product availability in remote areas at affordable prices. High prevalence rate of cardiovascular and infectious diseases, surging geriatric population, and wide-ranging product portfolios offered by companies to broaden their reach in the developing market in the LATAM region are poised to support business growth.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates and working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia Pacific
    • 1.2.4 Latin America
    • 1.2.5 MEA
  • 1.3 Forecast calculations
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Softgel capsules industry 360 degree synopsis, 2017 - 2030
    • 2.1.1 Business trends
    • 2.1.2 Type trends
    • 2.1.3 Application trends
    • 2.1.4 Manufacturers trends
    • 2.1.5 Regional trends

Chapter 3 Softgel Capsules Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2030
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Growing prevalence of chronic ailments such as cardiovascular diseases worldwide
      • 3.3.1.2 Increasing demand for plant-based capsules
      • 3.3.1.3 Rising number of ongoing clinical trials and novel product launches in the industry
      • 3.3.1.4 High investment in R&D for innovative manufacturing technology
    • 3.3.2 Industry pitfalls and challenges
      • 3.3.2.1 Loss of patent exclusivity
  • 3.4 Growth potential analysis
    • 3.4.1 By type
    • 3.4.2 By application
    • 3.4.3 By manufacturers
  • 3.5 COVID-19 impact analysis
  • 3.6 Porter's analysis
  • 3.7 Competitive landscape, 2021
    • 3.7.1 Competitive matrix analysis, 2021
  • 3.8 PESTEL analysis

Chapter 4 Softgel Capsules Market, By Type

  • 4.1 Key segment trends
  • 4.2 Gelatin based
    • 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.3 Vegetarian capsules
    • 4.3.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Softgel Capsules Market, By Application

  • 5.1 Key segment trends
  • 5.2 Health & dietary supplements
    • 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 5.2.2 Vitamins
      • 5.2.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 5.2.3 Enzymes
      • 5.2.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 5.2.4 Omega 3
      • 5.2.4.1 Market size, by region, 2017 - 2030 (USD Million)
    • 5.2.5 Minerals
      • 5.2.5.1 Market size, by region, 2017 - 2030 (USD Million)
    • 5.2.6 Others
      • 5.2.6.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.3 Prescription medicine
    • 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 5.3.2 Antibiotics & antivirals
      • 5.3.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 5.3.3 Cough & cold drugs
      • 5.3.3.1 Market size, by region, 2017 - 2030 (USD Million)
    • 5.3.4 Others
      • 5.3.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 6 Softgel Capsules Market, By Manufacturers

  • 6.1 Key segment trends
  • 6.2 Pharmaceutical companies
    • 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 6.3 Nutraceutical companies
    • 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 6.4 Others
    • 6.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 7 Softgel Capsules Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country 2017 - 2030 (USD Million)
    • 7.2.2 Market size, by type, 2017 - 2030 (USD Million)
    • 7.2.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.2.4 Market size, by manufacturers, 2017 - 2030 (USD Million)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size, by type, 2017 - 2030 (USD Million)
      • 7.2.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.2.5.3 Market size, by manufacturers, 2017 - 2030 (USD Million)
    • 7.2.6 Canada
      • 7.2.6.1 Market size, by type, 2017 - 2030 (USD Million)
      • 7.2.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.2.6.3 Market size, by manufacturers, 2017 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size, by country 2017 - 2030 (USD Million)
    • 7.3.2 Market size, by type, 2017 - 2030 (USD Million)
    • 7.3.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.3.4 Market size, by manufacturers, 2017 - 2030 (USD Million)
    • 7.3.5 Germany
      • 7.3.5.1 Market size, by type, 2017 - 2030 (USD Million)
      • 7.3.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.5.3 Market size, by manufacturers, 2017 - 2030 (USD Million)
    • 7.3.6 UK
      • 7.3.6.1 Market size, by type, 2017 - 2030 (USD Million)
      • 7.3.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.6.3 Market size, by manufacturers, 2017 - 2030 (USD Million)
    • 7.3.7 France
      • 7.3.7.1 Market size, by type, 2017 - 2030 (USD Million)
      • 7.3.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.7.3 Market size, by manufacturers, 2017 - 2030 (USD Million)
    • 7.3.8 Italy
      • 7.3.8.1 Market size, by type, 2017 - 2030 (USD Million)
      • 7.3.8.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.8.3 Market size, by manufacturers, 2017 - 2030 (USD Million)
    • 7.3.9 Spain
      • 7.3.9.1 Market size, by type, 2017 - 2030 (USD Million)
      • 7.3.9.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.9.3 Market size, by manufacturers, 2017 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country 2017 - 2030 (USD Million)
    • 7.4.2 Market size, by type, 2017 - 2030 (USD Million)
    • 7.4.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.4.4 Market size, by manufacturers, 2017 - 2030 (USD Million)
    • 7.4.5 China
      • 7.4.5.1 Market size, by type, 2017 - 2030 (USD Million)
      • 7.4.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.5.3 Market size, by manufacturers, 2017 - 2030 (USD Million)
    • 7.4.6 Japan
      • 7.4.6.1 Market size, by type, 2017 - 2030 (USD Million)
      • 7.4.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.6.3 Market size, by manufacturers, 2017 - 2030 (USD Million)
    • 7.4.7 India
      • 7.4.7.1 Market size, by type, 2017 - 2030 (USD Million)
      • 7.4.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.7.3 Market size, by manufacturers, 2017 - 2030 (USD Million)
    • 7.4.8 South Korea
      • 7.4.8.1 Market size, by type, 2017 - 2030 (USD Million)
      • 7.4.8.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.8.3 Market size, by manufacturers, 2017 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size, by country 2017 - 2030 (USD Million)
    • 7.5.2 Market size, by type, 2017 - 2030 (USD Million)
    • 7.5.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.5.4 Market size, by manufacturers, 2017 - 2030 (USD Million)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size, by type, 2017 - 2030 (USD Million)
      • 7.5.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.5.3 Market size, by manufacturers, 2017 - 2030 (USD Million)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size, by type, 2017 - 2030 (USD Million)
      • 7.5.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.6.3 Market size, by manufacturers, 2017 - 2030 (USD Million)
    • 7.5.7 Argentina
      • 7.5.7.1 Market size, by type, 2017 - 2030 (USD Million)
      • 7.5.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.7.3 Market size, by manufacturers, 2017 - 2030 (USD Million)
  • 7.6 Middle East and Africa
    • 7.6.1 Market size, by country 2017 - 2030 (USD Million)
    • 7.6.2 Market size, by type, 2017 - 2030 (USD Million)
    • 7.6.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.6.4 Market size, by manufacturers, 2017 - 2030 (USD Million)
    • 7.6.5 Saudi Arabia
      • 7.6.5.1 Market size, by type, 2017 - 2030 (USD Million)
      • 7.6.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.5.3 Market size, by manufacturers, 2017 - 2030 (USD Million)
    • 7.6.6 South Africa
      • 7.6.6.1 Market size, by type, 2017 - 2030 (USD Million)
      • 7.6.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.6.3 Market size, by manufacturers, 2017 - 2030 (USD Million)
    • 7.6.7 UAE
      • 7.6.7.1 Market size, by type, 2017 - 2030 (USD Million)
      • 7.6.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.7.3 Market size, by manufacturers, 2017 - 2030 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Competitive dashboard, 2021
  • 8.2 Eurocaps Ltd.
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 SWOT analysis
  • 8.3 Catalent Inc.
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 SWOT analysis
  • 8.4 Capsugel (Lonza)
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 SWOT analysis
  • 8.5 Aenova Group GmbH
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 Sirio Pharma Co.
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 Procaps Group
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 SWOT analysis
  • 8.8 Captek Softgel International Inc.
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 SWOT analysis
  • 8.9 Patheon
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 SWOT analysis
  • 8.10 Fuji Capsules Co. Ltd.
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 SWOT analysis
  • 8.11 Estrellus
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis
  • 8.12 Curtis Health Caps
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Product landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 SWOT analysis
  • 8.13 Delpharm Evreux
    • 8.13.1 Business overview
    • 8.13.2 Financial data
    • 8.13.3 Product landscape
    • 8.13.4 Strategic outlook
    • 8.13.5 SWOT analysis
  • 8.14 Guangdong Yichao Biological Co. Ltd.
    • 8.14.1 Business overview
    • 8.14.2 Financial data
    • 8.14.3 Product landscape
    • 8.14.4 Strategic outlook
    • 8.14.5 SWOT analysis
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제